Fortress Biotech (FBIO) Debt to Equity: 2013-2025
Historic Debt to Equity for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $0.73.
- Fortress Biotech's Debt to Equity rose 117.79% to $0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.73, marking a year-over-year increase of 117.79%. This contributed to the annual value of $2.55 for FY2024, which is 5.56% down from last year.
- Fortress Biotech's Debt to Equity amounted to $0.73 in Q3 2025, which was down 35.65% from $1.14 recorded in Q2 2025.
- In the past 5 years, Fortress Biotech's Debt to Equity registered a high of $4.54 during Q1 2023, and its lowest value of -$15.60 during Q1 2024.
- Its 3-year average for Debt to Equity is -$1.56, with a median of $0.73 in 2025.
- Over the last 5 years, Fortress Biotech's Debt to Equity had its largest YoY gain of 934.14% in 2023, and its largest YoY loss of 590.57% in 2023.
- Quarterly analysis of 5 years shows Fortress Biotech's Debt to Equity stood at $0.19 in 2021, then soared by 864.64% to $1.83 in 2022, then skyrocketed by 47.21% to $2.70 in 2023, then fell by 5.56% to $2.55 in 2024, then surged by 117.79% to $0.73 in 2025.
- Its last three reported values are $0.73 in Q3 2025, $1.14 for Q2 2025, and $1.74 during Q1 2025.